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INTRODUCTION 
The thickness of various underlying tissue layers were measured at 
locations where the overall thickness and, therefore, the ultrasound 
attenuation prior to the fetus appeared minimized. Identification of a 
worst case, or a small group of potentially high exposure situations, is 
necessary for the optimal design and use of ultrasound equipment. 
Appropriate measurements in these cases allow calculation of estimated 
intensities in situ for comparison with future actual measurements. While 
other types of examinations, for example, intraoperative imaging with a 
saline or water standoff, provide even less overlying attenuation, 
obstetrical applications are more numerous and warrant attention. 
Earlier estimates of attenuation of tissues overlying the fetus 
centered on first trimester pregnancy, and were summarized by the NCRP 
(1983). Those measurements used phase-sensitive ultrasound receivers and 
yielded relatively high transducer-to-gestational sac pressure losses. 
Attenuation estimates in the first and last trimester were suggested by 
Carson (1988), based on an informal search of worst cases in a few clinical 
examinations. These and the NCRP estimates yielded a total minimum 
attenuation at 3.5 MHz of 3.9 dB in the first trimester and 1.6 dB in the 
third trimester, from overlying tissue of thicknesses of 2.6 and 1.0 cm, 
respectively. These estimates, being lower than earlier estimates and 
measurements, suggested a need for specific worst case measurements. The 
second trimester cases was studied in this current work because of the 
expected fetal sensitivity to thermal and other insults at this stage and 
because the overlying tissue was expected to be thin relative to the first 
trimester. 
METHODS 
Ultrasound imaging for guidance of genetic amniocentesis provided a set 
of 22 patients in a limited, 15-20 week range of gestational ages. 
Subjects were selected randomly, independent of maternal size. Imaging was 
performed with a conventional sector scanner (Picker Artis, with a 5 or 3.5 
MHz transducer) and a standoff. Because of the known differences in 
attenuation coefficients, tissues were grouped into the following 
categories: Skin; subcutaneous fat; abdominal muscle or linea alba and 
fatty fascia (preperitoneal fat); and myometrium. The placenta and bladder 
were not included because they will not, in the worst cases, lie in the 
prefetal imaging path. 
To evaluate the effects of the standoff, the same plane was imaged in 
several patients with a linear array and with the sector scanner, with and 
without a standoff. Total thicknesses measured with the standoff and the 
linear array agreed within + 1 mm, while direct contact sector scanning 
depressed the thickness of overlying tissues by an average of 3.5 mm more 
than the other two methods. 
Attenuation coefficients used to calculate attenuation in the various 
tissue layers were the same as those employed by the NCRP (1983) and Carson 
(1988) except that skin is added separately here. In dBcm-IMHz -2, they 
were: skin - 1.5; subcutaneous fat - 0.46; abdominal (skeletal) muscle - 
0.51; preperitoneal fascia - 0.51; myometrium (smooth muscle) - 0.29. 
Fig. 1 shows individual measurements of thickness of overlying tissue 
layers and total overlying tissue thicknesses as a function of maternal 
weight. Linear regressions are shown as the solid lines. The one case at 
97 kg was not included in the linear regressions, because the data 
suggested that different anatomical relations may exist in this obese case. 
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Thicknesses as function of maternal weight for subcutaneous fat 
overlying the fetus and for the total of four layers. 
The minimum path length of attenuating tissue was only 1.7 cm, 
corresponding to an attenuation of 0.8 dBcm-iMHz -I or 2.8 dB at 3.5 MHz ; • 
A skin thickness of 1.3 mm was assumed for this minimum, while 2 mm was 
assumed for all other data points. Fig. 2 shows the calculated minimum 
attenuation at 3.5 MHz for individuals as a function of maternal weight 2 
Calculated attenuation correlates reasonably well with maternal weight (R 
= 0.68), and the latter might be used in some cases to estimate the former. 
The best fit linear regression shown in Fig. 2 as the central line, is 
given by: Attenuation (dB) = 0.i0 x Weight (kg) - 1.5. The 95% prediction 
limits are also plotted in Fig. 2. The lower 95% prediction limit is given 
approximately by: Attenuation2= 0.i0 x Maternal Weight - 3.3. Attenuation 
correlated almost as well (R = 0.57) with maternal anterior-posterior 
diameter. 
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Figure 2. Calculated attenuation by overlying tissues is shown as a 
function of maternal weight 
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